Expertise in
2
conditions

Claudio Di Cristofano

Rome, IT 
Expertise in
2
conditions
Rome, IT 

Overview

Claudio Di Cristofano practices practicing medicine in Rome, Italy.

Mr. Di Cristofano is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Osteosarcoma, Obesity, Lymphofollicular Hyperplasia, and Thyroidectomy.

He is actively involved in clinical research, co-authoring 63 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Rome, Italy
Other Locations
Latina, Italy
Sapienza, Italy
Aprilia, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Body Composition, Adiposity Phenotype, Metabolic Flexibility, and Gut Microbiota in PNPLA3 and TM6SF2 Gene Variant Carriers and Non-carriers With Nonalcoholic Fatty Liver Disease. Effects of a Nutritional Intervention Combined to Exercise
Body Composition, Adiposity Phenotype, Metabolic Flexibility, and Gut Microbiota in PNPLA3 and TM6SF2 Gene Variant Carriers and Non-carriers With Nonalcoholic Fatty Liver Disease. Effects of a Nutritional Intervention Combined to Exercise
Enrollment Status: Completed
Publish Date: May 27, 2022
Intervention Type: Dietary supplement, Other
Study Phase: Not Applicable
Role and Pathogenetic Mechanisms of Intestinal Microbiota in Non-alcoholic Fatty Liver Disease Severity in Obese and Non-obese Subjects
Role and Pathogenetic Mechanisms of Intestinal Microbiota in Non-alcoholic Fatty Liver Disease Severity in Obese and Non-obese Subjects
Enrollment Status: Completed
Publish Date: November 20, 2020
Intervention Type: Procedure
View 1 Less Clinical Trial

63 Total Publications

Complete response in metastatic clear cell renal cell carcinoma following pembrolizumab-axitinib and subsequent nephrectomy: a Case Report.
Complete response in metastatic clear cell renal cell carcinoma following pembrolizumab-axitinib and subsequent nephrectomy: a Case Report.
Journal: Frontiers in immunology
Published: February 14, 2026

Frequently Asked Questions about Claudio Di Cristofano

Is Claudio Di Cristofano a top-rated expert for Non-Alcoholic Fatty Liver Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Claudio Di Cristofano is classified as an Advanced expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Claudio Di Cristofano participate in research or clinical trials?

Yes. Claudio Di Cristofano has published 63 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Claudio Di Cristofano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Di Cristofano's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile